No reason for EU to discriminate AstraZeneca vaccine, says Khairy

Bernama
3 October, 2021
Updated:over 4 years ago

KUALA LUMPUR (July 6): The EU should not discriminate over where AstraZeneca vaccine are produced, as the same formula is used at all its manufacturing facilities, said the National Covid-19 Immunisation Programme (PICK) Coordinating Minister Khairy Jamaluddin.

In the wake of reports that the EU would only recognise the AstraZeneca vaccine approved by the European Medicines Agency, Khairy said he would get AstraZeneca to inform the EU that all their manufacturing sites implement good manufacturing practices (GMP).

“So there is absolutely no reason for the EU to discriminate one AZ  (AstraZeneca) facility from the other," he told a joint press conference on PICK development with Health Minister Dr Adham Baba here yesterday.

Khairy, who is also Science, Technology and Innovation Minister said he would also discuss the issue with the EU ambassador to Malaysia to get clarity on the actual immigration policy for the EU with regards to vaccination.

He said all countries should allow entry to travellers vaccinated with WHO-listed vaccines. 

“That would be the most fair outcome in the recognition of vaccines for travellers. As long as a vaccine has been listed by WHO, then countries should accept travellers who have been vaccinated using those vaccines,” he said.

Get the latest news @ www.EdgeProp.my

Subscribe to our Telegram channel for the latest stories and updates 

Click here for more property stories

Never miss out

Sign up to get breaking news, unique insights, event invites and more from EdgeProp.

Latest publications

Never miss out

Sign up to get breaking news, unique insights, event invites and more from EdgeProp.

CLOSEclear

Malaysia's Most
Loved Property App

The only property app you need. More than 200,000 sale/rent listings and daily property news.

App StoreGoogle Play
Mobile logo